無料プレビュー

Helus Pharma Inc. (HELP) · NASDAQ Global Market

プロフィール

CYBIN INC. develops and advances psychedelic-based therapeutics, focusing on psilocybin research and development. It offers clinical-stage drug candidates and associated research programs, alongside intellectual property assets related to psychedelic compounds and therapeutic platforms. Its key business segments include U.S. psilocybin research operations, an Ireland-based intellectual property and European research arm, and a U.K. subsidiary acquired to expand clinical and commercial capabilities. The company conducts research with academic and clinical research organizations and distributes

主要指標

株価: $10.72 (+2.00%)
時価総額: 7億ドル
PER（今期予想）: -4.0
PBR: 2.3
配当利回り: —
52週レンジ: $3.76 – $15.15
業種: Healthcare / Medical - Pharmaceuticals
上場: NASDAQ Global Market
構成銘柄: —

比較会社: RPRX Royalty Pharma plc、CORT Corcept Therapeutics Incorporated、WBA Walgreens Boots Alliance, Inc.、KNSA Kiniksa Pharmaceuticals International, plc、LQDA Liquidia Corporation、PBH Prestige Consumer Healthcare Inc.、LTGO Latigo Biotherapeutics Inc.、SVA Sinovac Biotech Ltd.

長期トレンド・直近動向・強気／弱気シナリオ・業績10年・バリュエーション・テクニカル・株主・役員・深掘り分析は会員向けです。

7日間無料で全文を読むログイン

次回決算: 2026-11-12 · 更新: 2026-10-09